Both in Medical Labs
Celcuity vs GRAIL
Over the past year CELC returned −8.1% and GRAL returned +59.7%; their daily moves had a correlation of 0.26.
CELC −8.1% GRAL +59.7%Growth of $1, one year, split-adjusted
| Metric | CELC | GRAL |
|---|---|---|
| Price | $69.13 | $143.43 |
| Market cap | $3.38B | $6.41B |
| Today | −0.25% | −9.75% |
| 1 month | −8.0% | +8.2% |
| 6 months | −45.0% | +165.3% |
| Year to date | −30.7% | +67.6% |
| 1 year | −6.6% | — |
| Revenue growth (YoY) | — | +25.7% |
| Gross margin | — | −28.1% |
| Net margin | — | −246.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 38.8× |
| Net cash | $809.0K | $861.6M |
| Dividend yield | — | — |
| Volatility (60d) | 52.9% | 103.3% |
| Short % of float | 25.7% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).